Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020198353 - MULTISPECIFIC AGENTS FOR TREATMENT OF CANCER

Publication Number WO/2020/198353
Publication Date 01.10.2020
International Application No. PCT/US2020/024707
International Filing Date 25.03.2020
IPC
C07K 16/28 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
28against receptors, cell surface antigens or cell surface determinants
A61K 39/395 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A61P 35/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
Applicants
  • FORTY SEVEN, INC. [US]/[US]
Inventors
  • MCCAMISH, Mark
  • VOLKMER, Jens-Peter
Agents
  • LIEBESCHUETZ, Joe
  • CELLI, Rosemarie
  • SATHER, Susan K.
  • SCHILLING, Stephen H.
  • CHANG, Cindy
Priority Data
62/824,21326.03.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) MULTISPECIFIC AGENTS FOR TREATMENT OF CANCER
(FR) AGENTS MULTISPÉCIFIQUES POUR LE TRAITEMENT DU CANCER
Abstract
(EN)
The invention provides multispecific agents having one arm binding CD47, and a second arm binding to CD24. The invention also provides multispecific agents having one arm binding to SIRPa and a second arm binding to siglec-10.
(FR)
L'invention concerne des agents multispécifiques comprenant un bras de liaison à CD47, et un second bras de liaison à CD24. L'invention concerne également des agents multispécifiques ayant un bras de liaison à la protéine SIRPa et un second bras de liaison à siglec-10.
Latest bibliographic data on file with the International Bureau